-
Estimating the Magnitude of a Pull Incentive for Antibiotic Development Using the STEDI Value Framework: An Example From Spain
Mar 10, 2025, 14:00 PM -
Impact Of Valbenazine On Improvements In Health-Related Quality of Life (HRQoL) In Patients With Tardive Dyskinesia (TD): EQ-5D-5L Results From A Phase 4 Randomized Withdrawal Study (NCT03891862)
Mar 10, 2025, 14:00 PM -
Methodology for Estimating Equal Value Life-Year for Standard Three-State Partitioned Survival Models
Mar 10, 2025, 14:00 PM -
Building an ROI Tool for Diabetes Prevention Programs in the Kingdom of Saudi Arabia
Mar 10, 2025, 14:00 PM -
PROM-ising Progress? Patient-Reported Outcome Measures in Orphan Labels
Mar 10, 2025, 14:00 PM -
Association between Exposure to GLP-1 Treatment and Pancreatitis Risk in Obesity Patients: A Retrospective Database Study
Mar 10, 2025, 14:00 PM -
Estimating US Cancer Prevalence With Community Oncology EHR-Based Datasets via National Benchmarks From SEER and NPCR
Mar 10, 2025, 14:00 PM -
Economic and Social Impact of Protection Against Light Exposure During In Vitro Fertilization (IVF) in Hungary
Mar 10, 2025, 14:00 PM -
Evaluating the Cost-Effectiveness of Polygenic Risk Score-Guided Breast Cancer Screening Using a Discrete Event Simulation Model
Mar 10, 2025, 14:00 PM -
The Impact of Family Spillover Effects in Economic Evaluation for SMA Type 1 Treatments in the United States
Mar 10, 2025, 14:00 PM -
Real-world Impact of the United States Preventive Services Task Force (USPSTF) Guidelines on HIV-1 Pre-Exposure Prophylaxis (PrEP) Ancillary Service Cost Sharing: Segmented Change Pre- and Post-Milestone USPSTF Timepoints
Mar 10, 2025, 14:00 PM -
Costs and Complications of Hospitalization among Survivors of S. aureusbacteremia in the US: A Multicenter Retrospective Cohort Study, 2020-2022
Mar 10, 2025, 14:00 PM -
Approaches to Model Patient And Carer Utilities and Disutilities of Adverse Events in Economic Models for Rare Disease Treatments in NICE Appraisals
Mar 10, 2025, 14:00 PM -
Natural History and Burden of Disease Among Patients With Juvenile GM2 Gangliosidoses in France
Mar 10, 2025, 14:00 PM -
Modeling in R: Tutorial for Beginner Using a Cost-Effectiveness Analysis Made With Microsoft Excel
Mar 10, 2025, 14:00 PM -
Validity of Diagnostic Codes to Identify Metastatic Prostate Cancer in Medicare Claims Database
Mar 10, 2025, 14:00 PM -
Understanding Japanese Subsidy Initiatives for Rare, Intractable Diseases
Mar 10, 2025, 14:00 PM -
The Role of Productivity Measures in Economic Evaluations of Migraine Therapies
Mar 10, 2025, 14:00 PM -
Impact of Cirrhosis on Health-Related Quality of Life and Activity Among Patients with Metabolic Dysfunction-Associated Steatohepatitis in France, Italy, Germany, and Canada
Mar 10, 2025, 14:00 PM -
Examination of Different Segments of Health Literacy and Health Awareness Among Pregnant Women
Mar 10, 2025, 14:00 PM
